U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lisdexamfetamine Dimesylate Tablet, Chewable
Status: Currently in Shortage
»Date first posted: 07/14/2023
»Therapeutic Categories: Psychiatry

Expand all

Novadoz Pharmaceuticals LLC (Reverified 02/17/2025)

Company Contact Information:
(855) 668-2369; customerservice@novadozpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) Available Limited Supplies Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) Available Limited Supplies Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) Available Limited Supplies Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) Available Limited Supplies Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) Available Limited Supplies Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) Available Limited Supplies Shortage of an active ingredient

Sun Pharmaceutical Industries, Inc. (Revised 04/04/2025)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) Limited Availability Q2 2025 Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) Limited Availability Q2 2025 Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) Limited Availability Q2 2025 Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) Limited Availability Q2 2025 Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) Limited Availability Q2 2025 Shortage of an active ingredient
Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) Limited Availability Q2 2025 Shortage of an active ingredient

Takeda Pharmaceuticals USA Inc. (Reverified 04/15/2025)

Company Contact Information:
877-TAKEDA-7 (1-877-825-3327)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) Available
Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) Available
Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) Available
Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) Available
Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) Available
Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) Available
Back to Top